Donald Trump has repeatedly accused Pfizer of helping Joe Biden win the 2020 election - Francis Chung/Politico/Bloomberg Donald Trump’s justice department is investigating claims that Pfizer delayed ...

The chapter on Pfizer and BioNTech’s mRNA patent feud with Germany’s CureVac is coming to a close, even as lawsuits over the vaccine technology continue to play out on several other fronts. Pfizer and ...

Oct 28 (Reuters) - Britain's GSK (GSK.L), opens new tab cautioned full-year earnings would likely come in at the lower end of its forecast range after the COVID-19 pandemic took a toll on its vaccines ...

CureVac (NASDAQ:CVAC) announced on Friday that the company and its partner, GSK (NYSE:GSK), are set to receive $740M and other payments, as Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) have agreed to ...

GlaxoSmithKline and Vir Biotechnology’s COVID-19 antibody drug sotrovimab resulted in a 79 percent reduction in the risk of hospitalization for more than 24 hours or death due to any cause, the ...

Following restricted vaccine approvals and changes to CDC immunization schedules, Merck, Pfizer, GSK and Sanofi are all ...

Shah Capital, Novavax's second-largest shareholder, is pressing the biotech's board to pursue strategic changes, including a ...

Interim results expected before year-end Full efficacy results possible as early as January Regeneron, Eli Lilly are ahead in antibody race The two partners in August started testing the antibody on ...

LONDON (AP) — Drugmakers Sanofi and GlaxoSmithKline say they will seek regulatory approval for a new COVID-19 vaccine after human trials showed it provided a high level of protection against the ...

GlaxoSmithKline and Vir Biotechnology, a San Francisco-based drugmaker that focuses on infectious diseases, said Aug. 31 that they have begun a clinical trial of an antibody drug to treat COVID-19.

The U.S. government will pay drugmakers Sanofi and GlaxoSmithKline up to $2.1 billion to develop and deliver 100 million doses of their potential coronavirus vaccine, the companies announced Friday.